Opportunities
Search

Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-05

Buyer: Deutsche Rentenversicherung Knappschaft-Bahn-See | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-05

Buyer: Akcinė bendrovė "Via Lietuva" | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-08-05

Buyer: Akcinė bendrovė "Via Lietuva" | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-08-05

Buyer: LESY Slovenskej republiky, štátny podnik | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-08-07

Buyer: Университетска многопрофилна болница за активно лечение "Света Екатерина" ЕАД | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-08-07

Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-10

Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-10

Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-10

Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-10

Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-10

Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-10

Buyer: GWQ ServicePlus AG | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-10

The National Institute on Drug Abuse (NIDA) Cutting-Edge Basic Research Award (CEBRA) is designed to foster highly innovative or conceptually creative research related to the etiology, pathophysiology, prevention, or treatment of substance use disorders (SUDs). It supports high-risk and potentially high-impact research that is sparse or not included in NIDA's current portfolio that has the potential to transform SUD research. The proposed research should: 1. develop, and/or adapt, revolutionary techniques or methods for addiction research or that show promising future applicability to SUD research; and /or 2. test an innovative and significant hypothesis for which there are scant precedent or preliminary data and which, if confirmed, would transform current thinking.

Buyer: Consejo de Administración-Comité de Inversiones de la Sociedad Estatal Correos y Telégrafos S.A | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-08-13

Buyer: MARIANUM - Pohrebníctvo mesta Bratislavy | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-08-15

Buyer: VĮ Turto bankas | Notice type: cn-standard | Procedure: restricted | Contract: services | Deadline: 2027-08-15

Buyer: SDIS du Pas-de-Calais | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-17

Buyer: Province de Liège | Notice type: cn-standard | Procedure: open | Contract: services | Deadline: 2027-08-17

Buyer: Consejo de Administración-Comité de Inversiones de la Sociedad Estatal Correos y Telégrafos S.A | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-08-17

The Blueprint Neurotherapeutics Network for Biologics (BPN-Biologics) provides support for biologic-based therapeutic discovery and development, from lead optimization through phase I clinical testing. This Funding Opportunity Announcement (FOA) supports preclinical discovery and development of potential therapeutic Biotechnology Products and Biologics including, but not limited to, large biologic macromolecules, (e.g., proteins, antibodies, and peptides), gene-based therapies (i.e., oligonucleotide- and viral-based), cell therapies, and novel emerging therapies (e.g., microbial and microbiome therapies). Applicants will collaborate with NIH-funded consultants and can augment their project with NIH contract research organizations (CROs) that specialize in manufacturing, scaling, pharmacokinetics, toxicology, and Phase I clinical testing. BPN-Biologics awardee institutions retain their assignment of IP rights and gain assignment of IP rights from the BPN-Biologics contractors (and thereby control the patent prosecution and licensing negotiations) for biotherapeutic candidates developed in this program.

Buyer: МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ - Д-Р СТАМЕН ИЛИЕВ АД | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-08-19

Buyer: AOK Niedersachsen. Die Gesundheitskasse. | Notice type: cn-standard | Procedure: open | Contract: supplies | Deadline: 2027-08-21

Buyer: МНОГОПРОФИЛНА БОЛНИЦА ЗА АКТИВНО ЛЕЧЕНИЕ "Д-Р ТОТА ВЕНКОВА" АД | Notice type: cn-standard | Procedure: restricted | Contract: supplies | Deadline: 2027-08-21

Through WaterSMART, the Bureau of Reclamation (Reclamation) leverages Federal and non- Federal funding to work cooperatively with States, Tribes, and other entities as they plan for and implement actions to increase water supply and hydropower reliability. The WaterSMART Program demonstrably advances Trump administration priorities, such as those identified in Presidential Executive Order 14154 (January 20, 2025): Unleashing American Energy (E.O. 14154) and Secretarial Order 3418, and aligns with other priorities and requirements, such as those identified in Presidential Executive Order 14332 (August 7, 2025): Improving Oversight in Federal Grantmaking (E.O. 14332). The WaterSMART Title XVI Water Reclamation and Reuse Projects NOFO invites eligible applicants to submit proposals for the planning, design, and/or construction of water reclamation and reuse projects. Title XVI projects develop and supplement urban and irrigation water supplies through water reuse, which provides growing communities with new sources of clean water, increases water management flexibility during times of shortage, and makes the water supply more reliable.